Determination of genomic profile to predict clinical response to FOLFOX plus bevacizumab in metastatic colorectal cancer.

Authors
Publication date
Publisher
'American Society of Clinical Oncology (ASCO)'
Doi

    Abstract

    Abstract is not available.

      Similar works

      Full text

      thumbnail-image

      Available Versions

      Crossref

      redirect
      oaiinfo:doi/10.1200%2Fjco.2011.29...
      Last time updated on 25/10/2020